Aspirin in the secondary prevention of cardiovascular disease

New England Journal of Medicine

Volumn 368, Issue 3, 2013, Pages 204-205

  Parekh, Anand K ^a   Galloway, James M ^a   Hong, Yuling ^b   Wright, Janet S ^b,c  

^a U S DEPARTMENT OF HEALTH AND HUMAN SERVICES   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c Center for Medicare and Medicaid Innovation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID;

CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; CLINICAL DECISION MAKING; CLINICAL EFFECTIVENESS; COST BENEFIT ANALYSIS; COST CONTROL; DRUG EFFECT; DRUG RESPONSE; EVIDENCE BASED MEDICINE; HEART INFARCTION; HEART PROTECTION; HUMAN; PATIENT ASSESSMENT; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SECONDARY PREVENTION; SHORT SURVEY; VASCULAR DISEASE;

EID: 84872451462     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMp1213380     Document Type: Article

References (5)

1. Heidenreich PA, Trogdon JG, Khavjou OA, et al. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation 2011;123:933-44.
2. Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics - 2012 update: a report from the American Heart Association. Circulation 2012;125(1):e2-e220. [Erratum, Circulation 2012;125(22):e1002.]
3. Antithrombotic Trialists' (ATT) Collaboration. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomized trials. Lancet 2009;373:1849-60.
4. Ademi Z, Liew D, Hollingsworth B, et al. Is it cost-effective to increase aspirin use in outpatient settings for primary or secondary prevention? Simulation data from the REACH Registry Australia Cohort. Cardiovasc Ther 2011 July 1 (Epub ahead of print).
5. Recommended use of aspirin and other antiplatelet medications among adults - National Ambulatory Medical Care Survey and National Hospital Ambulatory Medical Care Survey, United States, 2005-2008. MMWR Morb Mortal Wkly Rep 2012;61: Suppl:11-8.